Latest News of XLO
Can Xilio Therapeutics (NASDAQ:XLO) Afford To Invest In Growth?
By Yahoo! Finance |
4 months ago
Shareholders can still profit from a money-losing business if they buy it at the right price. Analyzing Xilio Therapeutics' cash burn and runway, it's crucial for the company to reduce spending or rai...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid
By Reuters |
6 months ago
By Bhanvi Satija and Sriparna Roy(Reuters) -Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cutting efforts a...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid demand
By Reuters |
6 months ago
By Bhanvi Satija and Sriparna Roy(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped Wall Street estimates on cost cuts, a smaller-than-fe...